Vault-13

VHCP Management II, LLC

New York, NY · CIK 1602263 · 13F filing filed 2020-02-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$379.4m reported value
20positions
94.1%in top 10
—no comparable previous quarter

Holdings, Q4 2019

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 10X GENOMICS INC CL A COM TXG TXG 1,786,431 $136.2m35.91% 35.91% —
2 AXSOME THERAPEUTICS INC COM AXSM AXSM 785,981 $81.2m21.42% 21.42% —
3 CONSTELLATION PHARMCETICLS I COM CNST CNST 1,500,631 $70.7m18.64% 18.64% —
4 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 462,903 $25.2m6.64% 6.64% —
5 SHOCKWAVE MED INC COM SWAV SWAV 288,838 $12.7m3.34% 3.34% —
6 IVERIC BIO INC COM OPHT OPHT 1,004,299 $8.6m2.27% 2.27% —
7 KALVISTA PHARMACEUTICALS INC COM KALV KALV 366,268 $6.5m1.72% 1.72% —
8 OBSEVA SA COM COM 1,573,639 $6.0m1.58% 1.58% —
9 MERSANA THERAPEUTICS INC COM COM 922,514 $5.3m1.39% 1.39% —
10 SPERO THERAPEUTICS INC COM SPRO SPRO 474,015 $4.6m1.20% 1.20% —
11 RELMADA THERAPEUTICS INC COM RLMD RLMD 114,876 $4.5m1.18% 1.18% —
12 ADVERUM BIOTECHNOLOGIES INC COM COM 383,620 $4.4m1.16% 1.16% —
13 MARINUS PHARMACEUTICALS INC COM MRNS MRNS 1,486,676 $3.2m0.85% 0.85% —
14 FORTY SEVEN INC COM FTSV FTSV 77,714 $3.1m0.81% 0.81% —
15 MILESTONE PHARMACEUTICALS IN COM MIST MIST 148,560 $2.4m0.63% 0.63% —
16 NEXTCURE INC COM COM 36,249 $2.0m0.54% 0.54% —
17 MYOVANT SCIENCES LTD COM MYOV MYOV 76,768 $1.2m0.31% 0.31% —
18 89BIO INC COM ETNB ETNB 41,235 $1.1m0.29% 0.29% —
19 BELLEROPHON THERAPEUTICS INC COM BLPH BLPH 659,087 $230.0k0.06% 0.06% —
20 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 32,211 $227.0k0.06% 0.06% —